You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬東醫療亮相ECR 2025!以品質構建全球信任
格隆匯 03-03 11:10

當AI遇見醫學影像,美的醫療以"工程師思維+臨牀洞察"雙引擎書寫另一種可能

鏈接歐洲標準,萬東醫療構建"全球佈局+本地響應"的創新服務模式

2025年歐洲放射年會(ECR)近日在維也納召開,作為全球放射學界的年度盛會,ECR再度吸引了全球目光。美的醫療板塊的萬東醫療攜AI智慧解決方案、無液氦超導磁共振、全幅DR等全系高端產品"如約而至",以MDR認證硬實力與本土化深耕成果,向世界展示中國智造的"技術引力"。

這場主題為"Planet Radiology"的年度盛會,融合環保理念與前沿醫學影像科技探索,匯聚全球頂尖學者與行業先鋒,共同為醫療影像的未來開疆拓土。

產品升維,AI賦能全球綠色醫療事業

萬東醫療以臨牀需求為出發點,推出AI一站式解決方案,將人工智能深度嵌入臨牀影像工作流程,改善設備掃描流程、提升成像效率質量,輔助醫生進行臨牀診斷、治療決策、介入手術等,不僅有效提升醫療效率,更可減少不必要的資源浪費。

其中,萬東自主研創的全球首台無液氦超導磁共振,以無液氦"黑科技",打破傳統磁共振對液氦資源的依賴,不僅降低了設備運行成本,更有效減少資源損耗,真正做到了科技領先+綠色發展"雙輪驅動"。

全幅 DR 則聚焦"低劑量精準成像",一次拍攝完成全脊柱/全下肢成像,無需拼接,有效降低患者輻射劑量,減少重複檢查。在保證診斷精度的同時,踐行綠色診療,以科技力量守護患者健康與生態環境。

探索深耕,中國智造贏得"歐洲認證"

憑藉優質產品及成熟的臨牀解決方案,"萬東裝備"在海外市場火速出圈,在深耕歐洲市場的十餘年中,更是成績斐然。以DR設備為例,產品本土裝機量突破700台,覆蓋東歐、南歐等重要市場,並在多個國家實現了規模化應用。其中,僅意大利單國裝機量便將近300台,保加利亞、波蘭、羅馬尼亞、西班牙、匈牙利等多個國家的訂單也紛至沓來。

這一亮眼成績的背後,是萬東醫療深厚的技術積澱與高度的市場洞察力。截至目前,萬東磁共振、CT及DR 全系產品均已獲得 MDR 認證,總獲證數量達38張。這些通往歐洲市場的堅實"通行證",可確保產品質量與性能符合歐洲標準。同時,萬東始終緊跟國際影像技術趨勢,在人工智能、綠色環保等領域不斷探索,在國際市場上贏得了廣泛好評。懷揣這份認可與信任,萬東醫療不斷努力,為世界更多地區的人們貢獻中國影像力量。

攜手並進,共話跨國醫療合作無限可能

為深化產品全球化佈局,當地時間2月27日,萬東醫療召開歐洲區域渠道會,聚焦歐洲及全球醫療市場發展機遇,與各方夥伴共謀共策。會議期間,與會代表就市場戰略、技術服務保障等核心議題展開深入研討,並在構建"全球佈局+本地響應"的創新服務模式方面達成多維協作模式。旨在讓更多醫患受益於高質量的醫療科技產品,共同推動全球醫學影像事業創新發展。

當AI遇見醫學影像,當中國智造鏈接歐洲標準,萬東醫療正以"工程師思維+臨牀洞察"的"雙引擎",書寫跨國醫療合作的另一種可能;與此同時,中國智造也將在不斷拓寬精準醫療邊界、打破傳統範式的過程中給予世界更多全新選項。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account